ganciclovir and atomolan there are incompatibility（更昔洛韦和atomolan不相容）.docVIP

Ganciclovir and Atomolan there are incompatibility [Abstract] Objective: to reduce the clinical treatment of adverse reactions, to ensure drug safety.: Both drugs were diluted with sterile water for injection 0.1ml mixed results: the emergence of light milky white, does not disappear after the shock. Conclusion: The clinical condition need to use two kinds of drugs should be used separately, and should not be a continuous infusion of the best middle infusion of 0.9% sodium chloride solution in order to avoid the occurrence of adverse reactions, even drugs degeneration. Keywords:] ganciclovir, Atomolan, incompatibility Injection of ganciclovir for the prevention and treatment of immunocompromised patients with cytomegalovirus infection, such as AIDS patients, cancer patients undergoing chemotherapy, organ transplant patients the use of immunosuppressive agents. The Atomolan injection for the treatment of viral hepatitis, severe hepatitis, active cirrhosis, fatty liver, alcoholic hepatitis, drug-induced hepatitis and the actions of liver fibrosis, cirrhosis of the liver. The author in May 2010 in the clinical ganciclovir and Atomolan, mixed, namely into a light milky, indicating the presence of incompatibility are reported below. 1 clinical data Admitted to our department in May 2010 of patients with viral hepatitis, patients with intravenous infusion of ganciclovir sodium chloride, and immediate replacement of 5% glucose 250ml Qaa glutathione 1.8g of the solution, we found two kinds of medicine liquid instantly form a light milky opacity in the Murphy dropper to prevent infusion reactions, immediately turn off the infusion regulator and timely replacement of the infusion, for saline infusion, did not have adverse consequences for patients, patients with no symptoms and complaint. 2 Experimental methods and results Ganciclovir 0.25g diluted with sterile water for injection 20ml, 1ml syringe extraction the the ganciclovir diluent and with